---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000431"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T18:27:32.224139+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Orthofix reports Q4 net sales $122.2M (-2% YoY); SeaSpine Q4 $63.2-63.7M (+13%+); merger closed Jan 5

## Summary
- Orthofix Q4 net sales $122.2M, down ~2% YoY; constant currency flat; Bone Growth Therapies up ~3%.
- SeaSpine Q4 net sales $63.2-63.7M, up >13% YoY; U.S. Spinal Implants +23%, U.S. Orthobiologics +19%.
- Full-year: Orthofix $460.7M (-0.8% as reported); SeaSpine ~$237.6M (+24% YoY).
- Cash: Orthofix $51M; SeaSpine $29M; Orthofix borrowed $30M on revolver for merger expenses.
- Merger of equals completed Jan 5; SeaSpine shareholders receiving 0.4163 OFIX shares per share.

## SEC filing metadata
- accession: 0000950170-23-000431
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/0000950170-23-000431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/ofix-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000431
- JSON: https://secwatch.observer/filing/0000950170-23-000431.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000431.txt

## Key facts
- Earnings Releases
  Orthofix Medical Inc. reported preliminary financial results for the fiscal quarter and year ended December 31, 2022.
  - Period: the fiscal quarter and year ended December 31, 2022
  - Result: preliminary results
  source text: On January 9, 2023, Orthofix Medical Inc. (the “Company”) issued a news release announcing, among other things, its preliminary unaudited net sales for the fiscal quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/0000950170-23-000431-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.